Skip to main content

Table 1 Characteristics of the all groups

From: Investigating the effect of quadruple therapy with Saccharomyces boulardii or Lactobacillus reuteri strain (DSMZ 17648) supplements on eradication of Helicobacter pylori and treatments adverse effects: a double-blind placebo-controlled randomized clinical trial

  Group C Group S Group P p value
Age (years)
Mean ± SD 46.57 ± 14.20 49.32 ± 13.42 47.38 ± 14.25 0.58
Sex
Male 34.6% (18) 48.1% (25) 34.6% (18) 0.26
Female 65.4% (34) 51.9% (27) 65.4% (34)
Smoking
Yes 17.3% (9) 32.7% (17) 19.2% (10) 0.12
No 82.7% (43) 67.3% (35) 80.8% (42)
Endoscopic reasons
Dyspepsia 59.6% (31) 67.3% (35) 67.3% (35) 0.63
Heart Burn 25% (13) 25% (13) 21.2% (11) 0.86
Endoscopic pattern of gastritis
Antral gastritis 92.3% (48) 82.7% (43) 90.4% (47) 0.26
Corpus gastritis 23.1% (12) 21.2% (11) 38.5% (20) 0.09
Pan-gastritis 3.8% (2) 11.5% (6) 3.8% (2) 0.22
Duodenal ulcer 3.8% (2) 0.0% (0) 1.9% (1) 0.77
Gastric ulcer 0.0% (0) 1.9% (1) 5.8% (3) 0.32
Esophagitis 0.0% (0) 0.0% (0) 0.0% (0)
Normal 1.9% (1) 1.9% (1) 0.0% (0) 1.00